| 08:00-08:10 |
Trans-nasal upper gastro-intestinal tract stenting under fluoroscopic control
Jonathan Jobling (Nottingham University Hospitals NHS Trust, UK)
|
| 08:10-08:20 |
Efficacy and safety of a novel multisegmented fully covered self-expanding metal stent for malignant esophageal obstruction: A prospective pilot study with historical controlJin Hee Noh (Hallym University, Korea)
|
| 08:20-08:30 |
Primary EUS-guided Hepaticogastrostomy for preoperative patients undergoing pancreatoduodenectomyNozomi Okuno (Aichi Cancer Center Hospital, Japan)
|
| 08:30-08:40 |
Long-term follow-up results after recanalization of completely obstructed strictures with magnetic compression anastomosisSung Ill Jang (Yonsei University, Korea)
|
| 08:40-08:50 |
Which kinds of tract-dilation device is suitable as the initial use during EUS-guided hepaticogastrostomy: A prospective randomized controlled trial (Wings Trial)Jun Matsuno (Osaka Medical and Pharmaceutical University, Japan)
|
| 08:50-09:00 |
P4HA2 interacted with ATAD3A to modulate PINK1/parkin-dependent mitophagy and iodine-125 brachytherapy sensitization in esophageal carcinomaCheng Feng (Southeast University, China)
|
| 09:00-09:10 |
Multi-stage automatic and rapid ablation and needle trajectory planning method for CT-guided percutaneous liver tumor ablationShengwei Li (Beijing Hospital, China)
|
| 09:10-09:20 |
Q&A
|
